
Abebe Alemu Fola (PhD)
@abebe_fola
Postdoc at Brown University | WEHI Allimun | - Infectious diseases genomic epidemiologist, malaria parasites drug and diagnostic resistance
ID: 880030659476992000
28-06-2017 11:50:34
98 Tweet
322 Followers
1,1K Following


So delighted to land @NatureMicrobiology. Thank you Jeff Bailey IDEEL Ethiopian Public Health Institute and all funders! Congratulations 🎊 👏 all co-authors

Work from Abebe Alemu Fola (PhD) et al., in Nature Microbiology finds #malaria strains with resistance to first-line drugs (#artemisinin) & diagnostics in #Ethiopia 🇪🇹💊⤵️ Jonathan Parr Jeff Bailey Ashenafi Assefa Emily Reichert nature.com/articles/s4156…


Congratulations Zach Popkin-Hall and Deus Ishengoma and msmt team.

"It allows us to bring in lots of African capabilities to work on these vaccines, and then this can be scaled up.” - Gates Foundation announce funding of $40 million to help develop mRNA vaccines in Africa in coming years. Together we can #endmalaria🦟 apnews.com/article/bill-g…

globalhealth.unc.edu/2023/10/malari… IDEEL Ethiopian Public Health Institute FMoHealthETH Gates Foundation Estée Torok WHO Ethiopia

Thanks Estée Torok and Gates Foundation for your support msmt and beyond.

Well done the team MSMT Deus Ishengoma Jeff Bailey IDEEL Estée Torok





Congratulations Jeff Bailey

Come join us, lets talk about malaria. Ethiopian Public Health Institute Ministry of Health ETHIOPIA Institute for Global Health & Infectious Diseases IDEEL Brown University Africa CDC Gates Foundation Jonathan Parr Khalid Beshir, PhD Estée Torok Abebe Alemu Fola (PhD) Sofonias K Tessema MESA - the malaria knowledge hub




Happy to share our pre-print. Great collaboration with Abebe Alemu Fola (PhD) Jeff Bailey In recent years, the susceptibility to Lumefantrine (ART partner drug) has decreased in isolates from West and Central Africa, with changes in the prevalence of pfmdr1 mutations captured by MIP seq
